Proposed Stages of Myocardial Phenotype Development in Fabry Disease
- PMID: 29778854
- DOI: 10.1016/j.jcmg.2018.03.020
Proposed Stages of Myocardial Phenotype Development in Fabry Disease
Abstract
Objectives: This study sought to explore the Fabry myocardium in relation to storage, age, sex, structure, function, electrocardiogram changes, blood biomarkers, and inflammation/fibrosis.
Background: Fabry disease (FD) is a rare, x-linked lysosomal storage disorder. Mortality is mainly cardiovascular with men exhibiting cardiac symptoms earlier than women. By cardiovascular magnetic resonance, native T1 is low in FD because of sphingolipid accumulation.
Methods: A prospective, observational study of 182 FD (167 adults, 15 children; mean age 42 ± 17 years, 37% male) who underwent cardiovascular magnetic resonance including native T1, late gadolinium enhancement (LGE), and extracellular volume fraction, 12-lead electrocardiogram, and blood biomarkers (troponin and N-terminal pro-brain natriuretic peptide).
Results: In children, T1 was never below the normal range, but was lower with age (9 ms/year, r = -0.78 children; r = -0.41 whole cohort; both p < 0.001). Over the whole cohort, the T1 reduction with age was greater and more marked in men (men: -1.9 ms/year, r = -0.51, p < 0.001; women: -1.4 ms/year, r = -0.47 women, p < 0.001). Left ventricular hypertrophy (LVH), LGE, and electrocardiogram abnormalities occur earlier in men. Once LVH occurs, T1 demonstrates major sex dimorphism: with increasing LVH in women, T1 and LVH become uncorrelated (r = -0.239, p = 0.196) but in men, the correlation reverses and T1 increases (toward normal) with LVH (r = 0.631, p < 0.001), a U-shaped relationship of T1 to indexed left ventricular mass in men.
Conclusions: These data suggest that myocyte storage starts in childhood and accumulates faster in men before triggering 2 processes: a sex-independent scar/inflammation regional response (LGE) and, in men, apparent myocyte hypertrophy diluting the T1 lowering of sphingolipid.
Keywords: Fabry disease; gender; native T1; phenotype.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Fabry Disease: Cardiomyopathy Staging.JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 2):1684-1685. doi: 10.1016/j.jcmg.2018.05.029. Epub 2018 Dec 12. JACC Cardiovasc Imaging. 2019. PMID: 30553671 No abstract available.
Similar articles
-
Cardiac Phenotype of Prehypertrophic Fabry Disease.Circ Cardiovasc Imaging. 2018 Jun;11(6):e007168. doi: 10.1161/CIRCIMAGING.117.007168. Circ Cardiovasc Imaging. 2018. PMID: 29853467 Free PMC article.
-
Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.J Cardiovasc Magn Reson. 2019 Aug 1;21(1):45. doi: 10.1186/s12968-019-0557-0. J Cardiovasc Magn Reson. 2019. PMID: 31366357 Free PMC article.
-
Myocardial Storage, Inflammation, and Cardiac Phenotype in Fabry Disease After One Year of Enzyme Replacement Therapy.Circ Cardiovasc Imaging. 2019 Dec;12(12):e009430. doi: 10.1161/CIRCIMAGING.119.009430. Epub 2019 Dec 12. Circ Cardiovasc Imaging. 2019. PMID: 31826677 Free PMC article.
-
The Role of Cardiac Imaging in the Diagnosis and Management of Anderson-Fabry Disease.JACC Cardiovasc Imaging. 2019 Jul;12(7 Pt 1):1230-1242. doi: 10.1016/j.jcmg.2018.11.039. JACC Cardiovasc Imaging. 2019. PMID: 31272606 Review.
-
Clinical applications of multiparametric CMR in left ventricular hypertrophy.Int J Cardiovasc Imaging. 2018 Apr;34(4):577-585. doi: 10.1007/s10554-018-1320-6. Epub 2018 Mar 3. Int J Cardiovasc Imaging. 2018. PMID: 29500729 Review.
Cited by
-
Developments in the treatment of Fabry disease.J Inherit Metab Dis. 2020 Sep;43(5):908-921. doi: 10.1002/jimd.12228. Epub 2020 Mar 2. J Inherit Metab Dis. 2020. PMID: 32083331 Free PMC article. Review.
-
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management.Card Fail Rev. 2023 Aug 8;9:e12. doi: 10.15420/cfr.2023.06. eCollection 2023. Card Fail Rev. 2023. PMID: 37602190 Free PMC article. Review.
-
Cardiovascular Magnetic Resonance and Sport Cardiology: a Growing Role in Clinical Dilemmas.J Cardiovasc Transl Res. 2020 Jun;13(3):296-305. doi: 10.1007/s12265-020-10022-7. Epub 2020 May 20. J Cardiovasc Transl Res. 2020. PMID: 32436168 Free PMC article. Review.
-
Hypertensive Heart Disease-The Imaging Perspective.J Clin Med. 2023 Apr 25;12(9):3122. doi: 10.3390/jcm12093122. J Clin Med. 2023. PMID: 37176563 Free PMC article. Review.
-
Society for Cardiovascular Magnetic Resonance 2023 Cases of SCMR case series.J Cardiovasc Magn Reson. 2024 Winter;26(2):101086. doi: 10.1016/j.jocmr.2024.101086. Epub 2024 Aug 22. J Cardiovasc Magn Reson. 2024. PMID: 39181403 Free PMC article. Review.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical